PaMeLa has been selected to participate in Global Navigator 2024, a program aimed at promoting international market expansion through collaboration with overseas medtech ecosystems. The program is jointly organized by MedTech Actuator and the Osaka Chamber of Commerce and Industry.

Global Navigator 2024 is an accelerator program specializing in the medical and healthcare fields, operating across Australia, Asia, and the Pacific region. PaMeLa’s CEO Goto and R&D Director Yamamoto will be participating in the program.

In October, PaMeLa is scheduled to speak at an event in Melbourne. During this visit, they will meet with medical institutions, government agencies, and companies, as well as engage with the local ecosystem.